Learn About Alopecia Totalis

What is the definition of Alopecia Totalis?
Alopecia totalis (AT) is a condition characterized by the complete loss of hair on the scalp. It is an advanced form of alopecia areata a condition that causes round patches of hair loss. Although the exact cause of AT is unknown, it is thought to be an autoimmune condition in which the immune system mistakenly attacks the hair follicles. Roughly 20% of affected people have a family member with alopecia, suggesting that genetic factors may contribute to the development of AT.
Save information for later
Sign Up
What are the alternative names for Alopecia Totalis?
  • Alopecia totalis
  • Loss of all scalp hair
Who are the top Alopecia Totalis Local Doctors?
BK
Dr. Brett A. King
Dermatology
Elite
Highly rated in
17
conditions
Dermatology

Yale New Haven Health System

Yale Dermatology

1625 Straits Turnpike 
Middlebury, CT 6762

Brett King is a Dermatologist in Middlebury, Connecticut. Dr. King has been practicing medicine for over 17 years and is rated as an Elite doctor by MediFind in the treatment of Alopecia Totalis. He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Alopecia Areata, Autosomal Recessive Hypotrichosis, Alopecia Totalis, and Alopecia Universalis. He is licensed to treat patients in Connecticut. Dr. King is currently accepting new patients.

View Profile
BC
Dr. Brittany G. Craiglow
Dermatology
Distinguished
Highly rated in
15
conditions
Dermatology

Yale New Haven Health System

Yale Dermatology Associates

425 Post Rd 
Fairfield, CT 6824

Brittany Craiglow is a Dermatologist in Fairfield, Connecticut. Dr. Craiglow has been practicing medicine for over 13 years and is rated as a Distinguished doctor by MediFind in the treatment of Alopecia Totalis. She is also highly rated in 15 other conditions, according to our data. Her top areas of expertise are Alopecia Universalis, Alopecia Areata, Alopecia Totalis, and Autosomal Recessive Hypotrichosis. She is licensed to treat patients in Connecticut. Dr. Craiglow is currently accepting new patients.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
SG
Sergio Galvan-Vano
Distinguished
Highly rated in
29
conditions

Universidad De Alcalá

Dermatology Department, Trichology Unit, Ramón Y Cajal University Hospital 
Madrid, MD, ES 

Sergio Galvan-Vano is in Madrid, Spain. Galvan-Vano is rated as a Distinguished expert by MediFind in the treatment of Alopecia Totalis. He is also highly rated in 29 other conditions, according to our data. His top areas of expertise are Female Pattern Baldness, Male Pattern Baldness, Autosomal Recessive Hypotrichosis, and Hirsutism in Women.

View Profile
View All Doctors
What are the latest Alopecia Totalis Clinical Trials?
The Efficacy of Combining 308 Nm-Excimer Light and Topical Steroid in the Treatment of Alopecia Areata
Status: Not yet recruiting
Start Date: April 1, 2021
Intervention Type: Combination Product
Phase: Phase 4
View Trial
Summary: Alopecia areata is a polygenic autoimmune disease causing hair loss, particularly during the anagen phase of hair growth This condition has a lifetime risk of about 2.1% of the world population and the cumulative incidence seems to rise linearly with age .~Patchy non scarring hair loss on the scalp is the most common clinical presentation, although it can also occur elsewhere . In addition to patc...
Match to trials
Find the right clinical trials for you in under a minute
Get started
A PHASE 2a, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE SAFETY OF RITLECITINIB (PF-06651600) IN ADULT PARTICIPANTS WITH ALOPECIA AREATA
Who is this study for: Adult patients with Alopecia Areata
Status: Active, not recruiting
Start Date: September 15, 2020
Intervention Type: Drug
Phase: Phase 2
View Trial
Summary: This is a global Phase 2a randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ritlecitinib in adults aged 18 to ≤50 years of age with ≥25% scalp hair loss due to Alopecia Areata (AA).
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Alopecia Totalis?
Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
Condition: Eyelash Loss in Alopecia Areata Totalis (AT) and Universalis (AU)
Journal: Dermatologic therapy
Treatment Used: Bimatoprost
Number of Patients: 17
Published: March 12, 2022
View publication
Summary: Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.
Condition: Alopecia Areata
Journal: Drug design, development and therapy
Treatment Used: Intramuscular Corticosteroid Therapy
Number of Patients: 101
Published: January 14, 2022
View publication
Summary: Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.
Tired of the same old research?
Check Latest Advances
Successful treatment of alopecia totalis with tofacitinib in a Danish patient.
Condition: Alopecia Totalis (AT)
Journal: Ugeskrift for laeger
Treatment Used: Tofacitinib
Number of Patients: 1
Published: August 25, 2020
View publication
Summary: Successful treatment of alopecia totalis with tofacitinib in a Danish patient.
View All Latest Advances